PROVIDER PROFILE · NPI 1023324035

David HerndonDO

PRACTICEFLORIDA CANCER AFFILIATES PLSee all providers at this practice →

Family PracticeNew Port Richey, FLI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

18,333

Beneficiaries

—

Total drug cost

$919K

Distinct drugs

158

Brand share

17.0%

Top prescribed drugs

Atorvastatin Calcium1,544 claims

Losartan Potassium933 claims

Levothyroxine Sodium699 claims

Amlodipine Besylate669 claims

Lisinopril607 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$468

Payment records

By payment type

Food and Beverage$468

Top paying entities

Food and Beverage$468

FACILITY AFFILIATIONS

Hospital & Facility Affiliations (2)

CCN 107797

Home health agency

CCN 101532

Hospice

REFERRAL NETWORK

Where David Herndon's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 0 inbound referrers · 4 outbound destinations.

Receives referrals from

Inbound — who sends patients here

No inbound pairs above the suppression threshold.

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
NEW PORT RICHEY HOSPITAL INC	80	109
Veselin Stoyanov Family Practice · New Port Richey, FL	26	70
Quest Diagnostics Clinical Laboratories Inc Clinical Laboratory · Tampa, FL	18	55
ALKHAFAJI, AZIZ	13	17

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history